The ability to achieve an early RYR1-RD diagnosis has been further aided by the development of multi-gene congenital myopathy panels which, due to greater availability and decreased cost, should be considered the standard approach when seeking to confirm a specific genetic etiology [54]. This evidence concerns the gene RYR1 and congenital myopathy.